Summit Trail Advisors, LLC Insmed Inc Transaction History

Summit Trail Advisors, LLC

  • $3.97 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 10, 2018
SELL
$20.0 - $29.72 $243,560 - $361,930
-12,178 Closed
0 $0
Q1 2018

May 22, 2018
SELL
$21.69 - $32.99 $5.15 Million - $7.83 Million
-237,419 Reduced 95.12%
12,178 $250,000
Q1 2018

May 21, 2018
BUY
$21.69 - $32.99 $5.41 Million - $8.23 Million
249,597 New
249,597 $250,000

Others Institutions Holding INSM

# of Institutions
465
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email